At the last BioPharma Asia in 2013, Oliver Nicolai from Celgene gave a presentation entitled:
Overcoming Impacts on FDA Regulations on Supply Chain Across Asia.
In this presentation, Oliver Nicolai touched on:
- Current commercial portfolio as well as significant potential of Celgene beyong 2015.
- Diversity and complexity of regional Asian countries.
- Factors that has major impacts on regional supply chain
- Regulation difference between Europe and Asia
- Celgene’s solution to gain flexibility in supply strategy
If this presentation interests you, you may want to consider attending the BioPharma Asia 2014 convention taking place in Singapore from 10-13 March 2014. For more information, you can download the event brochure here.